1UVQ | date | |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | ACY, BMA, FUC, GLY, NAG, ZN | enzyme |
| ||||||||||||
note | 1UVQ is a representative structure | ||||||||||||||
related structures | by homologous chain: 1IAK | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy., Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE, Svejgaard A, Bell JI, Strominger JL, Jones EY, Fugger L, Proc Natl Acad Sci U S A 2004 Feb 17;101(7):1999-2004. Epub 2004 Feb 9. PMID:14769912 |
Data retrieval |
View 1UVQ in 3D |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |